466 related articles for article (PubMed ID: 18786863)
1. Misoprostol for the prevention and treatment of postpartum haemorrhage.
Hofmeyr GJ; Gülmezoglu AM
Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1025-41. PubMed ID: 18786863
[TBL] [Abstract][Full Text] [Related]
2. Postpartum misoprostol for preventing maternal mortality and morbidity.
Hofmeyr GJ; Gülmezoglu AM; Novikova N; Lawrie TA
Cochrane Database Syst Rev; 2013 Jul; (7):CD008982. PubMed ID: 23857523
[TBL] [Abstract][Full Text] [Related]
3. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment.
Rajan PV; Wing DA
Clin Obstet Gynecol; 2010 Mar; 53(1):165-81. PubMed ID: 20142654
[TBL] [Abstract][Full Text] [Related]
4. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
Lam H; Tang OS; Lee CP; Ho PC
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):647-50. PubMed ID: 15225189
[TBL] [Abstract][Full Text] [Related]
5. Side-effects of oral misoprostol in the third stage of labour--a randomised placebo-controlled trial.
Hofmeyr GJ; Nikodem VC; de Jager M; Drakely A
S Afr Med J; 2001 May; 91(5):432-5. PubMed ID: 11455810
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
Al-Sawaf A; El-Mazny A; Shohayeb A
J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor.
Vaid A; Dadhwal V; Mittal S; Deka D; Misra R; Sharma JB; Vimla N
Arch Gynecol Obstet; 2009 Dec; 280(6):893-7. PubMed ID: 19277690
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings.
Lang DL; Zhao FL; Robertson J
BMC Pregnancy Childbirth; 2015 Nov; 15():305. PubMed ID: 26596797
[TBL] [Abstract][Full Text] [Related]
9. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.
Hofmeyr GJ; Gülmezoglu AM; Novikova N; Linder V; Ferreira S; Piaggio G
Bull World Health Organ; 2009 Sep; 87(9):666-77. PubMed ID: 19784446
[TBL] [Abstract][Full Text] [Related]
10. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour.
Afolabi EO; Kuti O; Orji EO; Ogunniyi SO
Singapore Med J; 2010 Mar; 51(3):207-11. PubMed ID: 20428741
[TBL] [Abstract][Full Text] [Related]
11. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
[TBL] [Abstract][Full Text] [Related]
12. The misoprostal third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage labour.
Amant F
BJOG; 2001 Mar; 108(3):338. PubMed ID: 11281484
[No Abstract] [Full Text] [Related]
13. Prostaglandins for preventing postpartum haemorrhage.
Gülmezoglu AM; Forna F; Villar J; Hofmeyr GJ
Cochrane Database Syst Rev; 2007 Jul; (3):CD000494. PubMed ID: 17636640
[TBL] [Abstract][Full Text] [Related]
14. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour.
Walley RL; Wilson JB; Crane JM; Matthews K; Sawyer E; Hutchens D
BJOG; 2000 Sep; 107(9):1111-5. PubMed ID: 11002954
[TBL] [Abstract][Full Text] [Related]
16. Prevention of postpartum hemorrhage with misoprostol.
Alfirevic Z; Blum J; Walraven G; Weeks A; Winikoff B
Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S198-201. PubMed ID: 17961574
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
[TBL] [Abstract][Full Text] [Related]
18. The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management.
El-Refaey H; Nooh R; O'Brien P; Abdalla M; Geary M; Walder J; Rodeck C
BJOG; 2000 Sep; 107(9):1104-10. PubMed ID: 11002953
[TBL] [Abstract][Full Text] [Related]
19. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
20. Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India.
Patted SS; Goudar SS; Naik VA; Bellad MB; Edlavitch SA; Kodkany BS; Patel A; Chakraborty H; Derman RJ; Geller SE
J Matern Fetal Neonatal Med; 2009 Jan; 22(1):24-8. PubMed ID: 19089777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
